drugset / Trial / NCT01481051

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

NCT01481051

Phase 2 Completed 57 enrolled Mati Therapeutics Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety and duration of the L-PPDS (latanoprost punctal plug delivery system) at different dose levels.

Timeline

Start
2011-11
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule